Calithera Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, net loss was USD 22.91 million compared to USD 34.71 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -31.03% | -50.00% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 97.45K | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |